))
Management & Proactive Care in EGFR+ mNSCLC Treatment
Manage episode 439565873 series 3599769
Conteúdo fornecido por OntadaLearn. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por OntadaLearn ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Welcome to episode three of three. In this episode, Dr. Alex Spira and Dr. Josh Zabari, both experts in thoracic oncology, delve into the common side effects experienced by patients undergoing treatment for locally Advanced or Metastatic EGFR+ Non-Small Cell Lung Cancer (NSCLC). They discuss the importance of early identification and management of these side effects to optimize patient care and prevent treatment discontinuation.
Listen in to review strategies for addressing dermatologic and gastrointestinal toxicities, the role of multidisciplinary teams, and the significance of continuous communication with patients and caregivers. This educational opportunity is brought to you by Johnson & Johnson.
5 episódios
Compartilhar
